
BUZZ-UK's Oxford Nanopore gains as CEO reportedly flags takeover exposure

Biotech group Oxford Nanopore Technologies (ONT.L) up as much as 5.7% at 115.9pGene sequencing specialist is now “exposed” to acquisition, CEO and co-founder Gordon Sanghera told FTONT’s shares have lost 85% since its peak in 2021“Bankers have said it could be attractive to one of the big diagnostics specialists, such as Thermo Fisher Scientificor Danaher,” FT report addsAs of last close, stock down ~15% this year
Biotech group Oxford Nanopore Technologies (ONT.L) up as much as 5.7% at 115.9p
Gene sequencing specialist is now “exposed” to acquisition, CEO and co-founder Gordon Sanghera told FT
ONT’s shares have lost 85% since its peak in 2021
“Bankers have said it could be attractive to one of the big diagnostics specialists, such as Thermo Fisher Scientific (TMO.N) or Danaher (DHR.N) ,” FT report adds
As of last close, stock down ~15% this year
